Article
Elevated expression of <i>RGS2</i> may underlie reduced olfaction in COVID-19 patients
2022-05-16
Abstract excerpt
Anosmia is common in COVID-19 patients, lasting for weeks or months following recovery. The biological mechanism underlying olfactory deficiency in COVID-19 does not involve direct damage to nasal olfactory neurons, which do not express the proteins required for SARS-CoV-2 infection. A recent study suggested that anosmia results from downregulation of olfactory receptors. We hypothesized that anosmia in COVID-19 m...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8a67128f-024f-5310-92d7-7df928c09945
- DOI
- 10.1101/2022.05.12.22274991
